张媛,女,1984年出生,博士,讲师。
2014年毕业于吉林大学,获得生物化学与分子生物学博士;2015年进入青岛大学医学部工作。博士期间主要研究方向为蛋白质的功能调节与神经损伤和修复,主要针对运用免疫疗法及小分子抗体药物进行预防和治疗阿尔茨海默病的相关研究。目前从事与神经系统疾病机制和治疗、以及非编码 RNA的调控机制等方面的研究。
主持国家自然科学基金青年基金项目1项,山东省自然科学基金项目1项,青岛市基础研究项目1项,以及中国博士后项目1项。发表SCI论文多篇,累积影响因子IF>30.6;申请国家发明专利2项。
研究方向
1. 阿尔茨海默病发病机制研究
2. 小分子抗体药物研究
代表论文:
1. Yuan Zhang*, Yanfang Zhao, Lei Zhang, Wanpeng Yu, Yu Wang, Wenguang Chang. Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer's Disease. Frontiers in Cellular Neuroscience. 2019, 13:339.
2. Yuan Zhang*, Lei Zhang, Yu Wang, Han Ding, Sheng Xue, Hongzhao Qi, Peifeng Li *. MicroRNAs or Long Noncoding RNAs in Diagnosis and Prognosis of Coronary Artery Disease. Aging and Disease. 2019, 10(2):353-366.
3. Yuan Zhang*, Lei Zhang, Yu Wang, Han Ding, Sheng Xue, Hua Yu, Longgang Hu, Hongzhao Qi, Yin Wang, Wenjie Zhu, Dacheng Liu, Peifeng Li*. KCNQ1OT1, HIF1A-AS2 and APOA1-AS are promising novel biomarkers for diagnosis of coronary artery disease. Clinical and experimental pharmacology and physiology. 2019, 46(7):635-642.
4. Yuan Zhang, Yuanhong Sun, Yangyang Huai, Yingjiu Zhang*, Functional characteristics and molecular mechanism of a new scFv antibody against Aβ42 oligomers and immature protofibrils, Molecular Neurobiology, 2015, 52(3):1269-1281.
5. Yuan Zhang, Xu Chen, Jinyu Liu, Yingjiu Zhang*, The protective effects and underlying mechanism of an anti-oligomeric Aβ42 single-chain variable fragment antibody, Neuropharmacology, 2015, 99:387-395.